Renal stones: From metabolic to physicochemical abnormalities. How useful are inhibitors?

Journal of Nephrology

Volumn 13, Issue 3 SUPPL., 2000, Pages

  Marangella, Martino ^a   Vitale, Corrado ^a   Petrarulo, Michele ^a   Bagnis, Cristiana ^a   Bruno, Michele ^a   Ramello, Adriano ^a  

^a MAURIZIANO HOSPITAL   (Italy)

Author keywords

Hypercalciuria; Hyperoxaluria; Hypocitraturia; Inhibitors of crystallization; Nephrolithiasis

Indexed keywords

BIOLOGICAL MODEL; CHEMISTRY; CRYSTALLIZATION; HUMAN; METABOLIC DISORDER; NEPHROLITHIASIS; PHYSICAL CHEMISTRY; REVIEW; URINE;

CHEMISTRY, PHYSICAL; CRYSTALLIZATION; HUMANS; KIDNEY CALCULI; METABOLIC DISEASES; MODELS, BIOLOGICAL; URINE;

EID: 0034322426     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Finlayson B. Physicochemical aspects of urolithiasis. Kidney Int 1978; 13: 344-60.
2. Kok DJ, Khan SR. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 1994; 46:847-54.
3. Mandel N, Riese R. Crystal-cell interactions: crystal binding to rat renal papillary tip collecting duct cells in culture. Am J Kidney Dis 1991; 17: 402-6.
4. Ryall RL. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation. World J Urol 1997; 15: 155-64.
5. Coe FL, Nakagawa Y, Parks JH. Inhibitors within the nephron. Am J Kidney Dis 1991; 17: 407-13.
6. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BE. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract N Engl J Med 1976; 294: 249-52.
7. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997; 51: 894-900.
8. Kok DJ, Schell-Feith EA. Risk factors for crystallization in the nephron: the role of renal development. J Am Soc Nephrol 1999; 10(suppl 14): S364-70.
9. Lieske JC, Deganello S. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol 1999; 10 (suppl 14): S422-9.
10. Drach GW, Perin R, Jacobs S. Outpatient evaluation of patients with calcium urolithiasis. J Urol 1979; 121: 564-7.
11. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, Me Guire J, Sakhaee, Bush S, Nicar M, Norman D, Peters P. Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19-30.
12. Preminger GM. The metabolic evaluation of patients with recurrent nephrolithiasis: A review of comprehensive and simplified approaches. J Urol 1989; 141: 760-3.
13. Hess B, Hasler-Strnb U, Ackermann D, Jaeger P. Metabolic evaluation of patients with recurrent calcium nephrolithiasis. Nephrol Dial Transplant 1997; 12:1362-8.
14. Marangella M. Metabolic evaluation of calcium nephrolithiasis. J Nephrol 1995; 8: 179-84.
15. Baggio B. J Nephrol Ibidem
16. Marangella M, Daniele PG, Ronzani M, Sonego S, Linari F. Urine saturation with calcium salts in normal subjects and idiopathic calcium stone formers estimated by an improved computer model system. Urol Res 1985; 3: 189-93.
17. Coe FL, Favus MJ. Disorders of stone formation. In: Brenner BM, Rector FC eds. The Kidney. Philadelphia: Saunders WB 1986; 1403-42.